The effect of medicines on women and men can differ significantly. This also applies to the currently most promising anti-aging drug rapamycin, as researchers from the Max Planck Institute for Biology of Ageing in Cologne ...
Dec 1, 2022
0
184
A review of the international use of a commonly prescribed family of antibiotics has found discrepancies in the safety data issued by regulatory bodies.
Dec 1, 2022
0
17
Faulty batches of generic lamotrigine tablets—an anti-convulsant drug commonly used for treating bipolar disorder and epilepsy—are being dispensed to patients in Australia. The compromised product is likely a result of ...
Nov 30, 2022
0
25
The growing list of COVID complications is long and surprising—from brain changes and heart disease to skin rashes and COVID toes.
Oct 13, 2022
0
4
As of late September 2022, nearly 78% of U.S. adults but only 31% of children ages 5 to 11 had completed the primary set of vaccinations against COVID-19, according to health authorities.
Oct 3, 2022
0
15
The U.S. Food and Drug Administration granted regular approval to capmatinib (Tabrecta) for adult patients with metastatic non-small cell lung cancer (NSCLC) whose tumors have a genetic mutation leading to mesenchymal-epithelial ...
Aug 15, 2022
0
6
Edgewell Personal Care Co. has recalled three batches of its Banana Boat Hair & Scalp Sunscreen Spray SPF 30 because trace levels of benzene were found in some samples during an internal review.
Aug 1, 2022
0
3
In a study published in BMJ Open, researchers at the University of Liverpool have identified an increasing trend in medicine-related harm leading to hospital admission.
Jul 5, 2022
0
2
Use of drug interaction checkers could have identified several drug-drug interaction (DDI)-associated adverse drug reactions, including severe and life-threatening events among patients with COVID-19, according to a review ...
Apr 25, 2022
0
2
Vijoice (alpelisib) has been granted accelerated approval for severe PIK3CA-related overgrowth spectrum (PROS), the U.S. Food and Drug Administration announced April 6.
Apr 19, 2022
0
2
